Chronic Obstructive Pulmonary Disease: Clinical Trials

90 trials for Chronic Obstructive Pulmonary Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

90 completed. 90 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 490Completed 90

Follow Chronic Obstructive Pulmonary Disease: new trials by email Literature Review of Chronic Obstructive Pulmonary Disease trials Research Report on Chronic Obstructive Pulmonary Disease

Trials (filtered) newest first · largest first

All 90 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 4 COPD and Suboptimal Inspiratory Flow Rate
Revefenacin, Tiotropium, Revefenacin Placebo - Chronic Obstructive Pulmonary Disease
Phase 4CompletedTheravance Biopharma4042022-01-072024-12-20
CHF5993 and CHF1535 pMDI on Lung Hyperinflation and Exercise Endurance Time in Subjects With COPD
CHF5993, CHF1535, Matched placebo - Chronic Obstructive Pulmonary Disease
Phase 4CompletedChiesi Farmaceutici S.p.A.1062021-10-282023-03-24
Comparison of Time to Extubation Using Sugammadex or Neostigmine
neostigmine/glycopyrrolate, sugammadex - Neuromuscular Blockade, Chronic Obstructive Pulmonary Disease
Phase 4CompletedTemple University582021-04-082024-03-13
Bacillus Calmette-guérin Vaccination to Prevent COVID-19
BCG vaccine, Placebo - COVID-19, Virus Diseases
Phase 4CompletedHellenic Institute for the Study of Sepsis3012020-05-262021-05-11
Association of Cathelicidin and Vitamin D Levels With the Category and Course of COPD
Cholecalciferol Liquid - Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease Moderate
Phase 4CompletedKaraganda Medical University1202020-02-182024-04-12
Effects of Spiolto® Respimat® (Tiotropium/Olodaterol) on Cardiac Function in Hyperinflated COPD Subjects
Olodaterol-Tiotropium - Chronic Obstructive Pulmonary Disease
Phase 4CompletedFraunhofer-Institute of Toxicology and Experimental Medicine322020-01-282023-04-26
Effects of HFOT on Exercise Performance in Patients With COPD. A Randomized, Controlled Trial.
High-flow oxygen therapy (HFOT), Low-flow oxygen therapy (LFOT) - Chronic Obstructive Pulmonary Disease
Phase 4CompletedUniversity of Zurich792019-05-202020-02-06
Beta-blockers to Patients With Chronic Obstructive Pulmonary Disease
Metoprolol, Standard care - Chronic Obstructive Pulmonary Disease
Phase 4CompletedOle Frobert, MD, PhD17132018-06-122026-08-12
Effect of Acetazolamide on Lung Water Content by Ultrasound in Patients With Respiratory Disease at Altitude
ACETAZOLAMIDE oral capsule, Placebo oral capsule - Chronic Obstructive Pulmonary Disease
Phase 4CompletedUniversity of Zurich1122018-05-222021-11-05
Differential Mechanisms of Dyspnea Relief in Advanced COPD: Opiates vs. Bronchodilators
Fentanyl Citrate, Combivent - Chronic Obstructive Pulmonary Disease
Phase 4CompletedDr. Denis O'Donnell202017-09-202024-04-03
Clinical Trial of Efficacy and Safety of Rengalin in the Treatment of Cough in Patients With Chronic Obstructive Pulmonary Disease
Rengalin, Placebo - Chronic Obstructive Pulmonary Disease
Phase 4CompletedMateria Medica Holding2382017-06-162020-12-11
INvestigating COPD Outcomes, Genomics and Neutrophilic Inflammation With Tiotropium and Olodaterol
Tiotropium & olodaterol, fluticasone furoate & vilanterol - Chronic Obstructive Pulmonary Disease
Phase 4CompletedUniversity of Dundee802017-06-012020-07-20
Effect of Acetazolamide on Exercise Performance in Patients With Respiratory Disease at Altitude
ACETAZOLAMIDE oral capsule, Placebo oral capsule - Chronic Obstructive Pulmonary Disease
Phase 4CompletedUniversity of Zurich1762017-05-242019-08-16
Effect of Acetazolamide on Postural Control in Patients With Respiratory Disease at Altitude
ACETAZOLAMIDE oral capsule, Placebo oral capsule - Chronic Obstructive Pulmonary Disease
Phase 4CompletedUniversity of Zurich1272017-05-242021-10-12
Effect of Acetazolamide on Right Ventricular Function at Rest in Patients With Respiratory Disease at Altitude
ACETAZOLAMIDE oral capsule, Placebo oral capsule - Chronic Obstructive Pulmonary Disease
Phase 4CompletedUniversity of Zurich1102017-05-242019-08-14
Effect of Acetazolamide on Right Ventricular Function During Exercise in Patients With Respiratory Disease at Altitude
ACETAZOLAMIDE oral capsule, Placebo oral capsule - Chronic Obstructive Pulmonary Disease
Phase 4CompletedUniversity of Zurich1102017-05-242019-08-14
Effect of Acetazolamide on Sleep Related Breathing Disturbances in Patients With Respiratory Disease at Altitude
ACETAZOLAMIDE oral capsule, Placebo oral capsule - Chronic Obstructive Pulmonary Disease
Phase 4CompletedUniversity of Zurich1852017-05-242019-01-29
The Effect of STIOLTO™ RESPIMAT® on Fatigue in Chronic Obstructive Pulmonary Disease
Stiolto Respimat, Placebo Respimat - Chronic Obstructive Pulmonary Disease
Phase 4CompletedLundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center142017-03-012020-08-06
Effects of Dual Bronchodilator Treatment on Cardiopulmonary Interactions in COPD
Tiotropium + Olodaterol, PLACEBO - Chronic Obstructive Pulmonary Disease
Phase 4CompletedQueen's University252017-01-012019-02-05
Microbiome Use to Stratify Use of Inhaled Corticosteroids: MUSIC Trial
Budesonide & formoterol fumarate and Aclidinium bromide, Fluticasone 500 & salmeterol and Aclidinium bromide, Fluticasone 250 & salmeterol and Aclidinium bromide - Chronic Obstructive Pulmonary Disease
Phase 4CompletedUniversity of Dundee1582016-12-012020-07-20

Showing 20 of 90. Sign in to see all of them.

Narrower conditions

Pulmonary Disease, Chronic Obstructive (90)  ·  Emphysema (10)  ·  Motor Activity (7)  ·  Dyspnea (5)  ·  Lung Diseases, Obstructive (5)  ·  Bronchitis (4)  ·  Lung Diseases (4)  ·  Asthma (3)  ·  Bronchitis, Chronic (3)  ·  Inflammation (2)  ·  Respiratory Tract Diseases (2)  ·  Anxiety Disorders (1)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  COVID-19 (1)  ·  Cardiovascular Diseases (1)

Broader conditions

Chronic Disease (90)  ·  Disease Attributes (90)  ·  Pathologic Processes (90)  ·  Pathological Conditions, Signs and Symptoms (90)  ·  Respiratory Tract Diseases (88)  ·  Lung Diseases (86)  ·  Lung Diseases, Obstructive (85)  ·  Bronchial Diseases (11)  ·  Behavior (10)  ·  Infections (9)  ·  Respiratory Tract Infections (8)  ·  Respiration Disorders (6)  ·  Signs and Symptoms (5)  ·  Signs and Symptoms, Respiratory (5)  ·  Bronchitis (4)

Interventions

Tiotropium Bromide (13)  ·  Budesonide (7)  ·  Formoterol Fumarate (7)  ·  Glycopyrrolate (7)  ·  indacaterol (7)  ·  Acetazolamide (6)  ·  Salmeterol Xinafoate (6)  ·  Fluticasone (5)  ·  tiotropium-olodaterol (4)  ·  Albuterol (3)  ·  Fluticasone-Salmeterol Drug Combination (3)  ·  aclidinium bromide (3)  ·  indacaterol-glycopyrronium combination (3)  ·  Albuterol, Ipratropium Drug Combination (2)  ·  Bisoprolol (2)

Sponsors

Novartis Pharmaceuticals (10)  ·  University of Zurich (7)  ·  AstraZeneca (5)  ·  University of Dundee (4)  ·  Queen's University (3)  ·  Dartmouth-Hitchcock Medical Center (2)  ·  Imperial College London (2)  ·  Laval University (2)  ·  Sumitomo Pharma America, Inc. (2)  ·  Ataturk University (1)  ·  Baqiyatallah Medical Sciences University (1)  ·  Centre Hospitalier Universitaire de Besancon (1)  ·  Chiesi Farmaceutici S.p.A. (1)  ·  Dr. Denis O'Donnell (1)  ·  Eisai Co., Ltd. (1)

Countries

United Kingdom (16)  ·  United States (13)  ·  Canada (12)  ·  Germany (9)  ·  Kyrgyzstan (7)  ·  Spain (7)  ·  Brazil (5)  ·  Belgium (4)  ·  Denmark (4)  ·  Italy (4)  ·  Netherlands (4)  ·  Russia (4)  ·  Sweden (4)  ·  Switzerland (3)  ·  Argentina (2)

Top investigators

Talant M Sooronbaev, MD (6)  ·  Konrad E Bloch, MD (5)  ·  Silvia Ulrich, MD (3)  ·  Denis E O'Donnell, MD (2)  ·  James Chalmers, MBChB, MRCP (2)  ·  Aina Noguera, Medicine (1)  ·  Aklak B Choudhury, MRCP (1)  ·  Aleksander V Zhestkov, Professor (1)  ·  Alyn H Morice, Professor (1)  ·  Amanda Iglesias, Biology (1)  ·  Ana Moragas, Family doc. (1)  ·  Andrei D Protasov, Professor (1)

Results publications

PMID 15229100, PMID 16113473, PMID 16235327, PMID 17646228, PMID 17951276, PMID 18162137, PMID 18584227, PMID 18804362, PMID 19208459, PMID 19245725, PMID 19532028, PMID 19711095, PMID 19808130, PMID 19875684, PMID 19875685, PMID 19878590, PMID 20040610, PMID 20498416, PMID 20576731, PMID 20692140, PMID 21145720, PMID 21558357, PMID 22250141, PMID 22791991, PMID 22923662, PMID 23682979, PMID 23715032, PMID 23807094, PMID 24484754, PMID 24549160, PMID 25504992, PMID 25673981, PMID 25684586, PMID 26152326, PMID 26549785, PMID 26719947, PMID 26752024, PMID 26917577, PMID 27174882, PMID 27239929, PMID 27812637, PMID 27940287, PMID 28679611, PMID 28877027, PMID 29025008, PMID 29488477, PMID 29625777, PMID 29763572, PMID 29797235, PMID 30138422

NIH funding

2017 (6), 2016 (2), 2009 (1), 2015 (1)